Barry H. Dash has made a notable investment in Elite Pharmaceuticals, acquiring 100,000 shares on October 9, 2026. This acquisition raises his total ownership to 3,365,555 shares. Such a significant purchase highlights Dash's confidence in the company's future prospects.

Elite Pharmaceuticals, based in Northvale, New Jersey, operates in the pharmaceutical preparations sector. The company is publicly traded under the ticker symbol ELTP. Recent filings indicate that Dash has been actively involved with the company, as seen in his previous transactions.

According to the recent SEC filing, Dash's transaction was executed at a price of $0.2598 per share. Following this acquisition, Dash holds a direct ownership stake, indicating his commitment to the company's growth and development.

The implications of this acquisition may extend to other stakeholders and investors, as insider transactions often serve as indicators of confidence in a company's performance. Dash's increased stake may also influence the perceptions of analysts and competitors within the pharmaceutical preparations industry.

Details were not available in the SEC filing regarding any upcoming events or further actions following this acquisition.

Ownership and Role

Barry H. Dash serves as a director at Elite Pharmaceuticals, which underscores his involvement and influence within the company. His role as a director may provide him with additional insights into the company's strategic direction and operational performance.

Transaction Details

The recent acquisition of 100,000 shares on October 9, 2026, was executed under the transaction code 'P', indicating a purchase. Following this transaction, Dash's total ownership now stands at 3,365,555 shares, reflecting his significant investment in the company.

Company Background

Elite Pharmaceuticals, incorporated in New Jersey, operates within the pharmaceutical preparations sector, classified under the Standard Industrial Classification code 2834. The company has undergone a name change from its former designation as Elite Pharmaceuticals Inc /DE/ on January 21, 1998.

"The company is publicly traded under the ticker symbol ELTP, and its fiscal year ends on March 31."

Contact Information

Elite Pharmaceuticals is located at 165 Ludlow Avenue, Northvale, NJ 07647, and can be reached at the business phone number 201-750-2646.